Are Sanofi, CMA CGM, or LVMH making a pact with Trump? Let's give them a good dose of economic patriotism!

To never miss a post from Jean-Christophe Féraud, subscribe to our columnists' newsletters .

Globalized capitalism and its CAC 40 champions have no homeland, or rather, they only have one flag: that of superprofits and dividends paid to shareholders. The complete opposite of the world of work and the vast majority of French employees who struggle to make ends meet, but know what economic patriotism is, out of conviction as much as necessity. You don't have to be a disillusioned old Marxist to stumble upon this cold reality: the former have an unfortunate tendency to turn their backs on their country as soon as the winds of money change; the latter desperately defend their jobs swept away by the waves of offshoring and are the best advocates of "made in France." It's not binary, it's factual.

A new illustration of this is the announcement made on Wednesday evening, May 14, by the pharmaceutical company Sanofi , which wants to "invest at least 20 billion dollars in the United States by 2030" to "considerably increase its research spending there."